Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation, and cardiomyopathy
Open Access
- 1 January 1997
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 20 (1) , 7-10
- https://doi.org/10.1002/clc.4960200104
Abstract
Advances in the understanding of the biochemistry of the mechanism of hemostasis have led to the development of sensitive methods for determining levels of markers which reflect thrombin activity (thrombin‐antithrombin III complex, fibrinopeptide A, F1+2 fragment), active fibrinolysis (D‐dimer, plasmin‐α2‐plasmin inhibitor complex), and platelet activity (platelet factor 4, ß‐thromboglobulin) in vivo. Measurement of these markers may be useful in identifying patients with various cardiovascular disorders at high risk of thromboembolism.Keywords
This publication has 35 references indexed in Scilit:
- Coagulation activity is increased in the left atrium of patients with mitral stenosisJournal of the American College of Cardiology, 1995
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- Measurement of Plasma D-Dimer for Diagnosis of Deep Venous ThrombosisAmerican Journal of Clinical Pathology, 1989
- Cardiogenic Brain EmbolismArchives of Neurology, 1986
- Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis.Stroke, 1984
- Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.Stroke, 1983
- Cerebral embolism in the Michael Reese Stroke Registry.Stroke, 1983
- Epidemiologic assessment of chronic atrial fibrillation and risk of strokeNeurology, 1978
- Natural History of Mitral Stenosis: A ReviewCirculation, 1972
- THE COURSE OF MITRAL STENOSIS WITHOUT SURGERY: TEN- AND TWENTY-YEAR PERSPECTIVESAnnals of Internal Medicine, 1960